These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3027852)

  • 1. Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results.
    Phillips P; Fetchick R; Weisman I; Foshee S; Graybill JR
    Rev Infect Dis; 1987; 9 Suppl 1():S87-93. PubMed ID: 3027852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of mycoses with itraconazole.
    Tucker RM; Williams PL; Arathoon EG; Stevens DA
    Ann N Y Acad Sci; 1988; 544():451-70. PubMed ID: 2850754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.
    Dupont B; Drouhet E
    Rev Infect Dis; 1987; 9 Suppl 1():S71-6. PubMed ID: 3027850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of two years of clinical experience with ketoconazole.
    Symoens J; Moens M; Dom J; Scheijgrond H; Dony J; Schuermans V; Legendre R; Finestine N
    Rev Infect Dis; 1980; 2(4):674-87. PubMed ID: 6255549
    [No Abstract]   [Full Text] [Related]  

  • 8. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral antifungal therapy. Current status of ketoconazole.
    Varkey B
    Postgrad Med; 1983 Jan; 73(1):52-3. PubMed ID: 6294644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polypeptide antifungal agent (X-5079C): further studies in 39 patients.
    Witorsch P; Andriole VT; Emmons CW; Utz JP
    Am Rev Respir Dis; 1966 Jun; 93(6):876-88. PubMed ID: 5328893
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole: a new triazole antifungal agent.
    Zuckerman JM; Tunkel AR
    Infect Control Hosp Epidemiol; 1994 Jun; 15(6):397-410. PubMed ID: 8083506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Itraconazole in the treatment of deep mycoses].
    Viviani MA; Tortorano AM
    Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral itraconazole therapy for mycotic keratitis.
    Thomas PA; Abraham DJ; Kalavathy CM; Rajasekaran J
    Mycoses; 1988 May; 31(5):271-9. PubMed ID: 2843767
    [No Abstract]   [Full Text] [Related]  

  • 17. Itraconazole in the treatment of human mycoses: review of three years of clinical experience.
    Cauwenbergh G; De Doncker P; Stoops K; De Dier AM; Goyvaerts H; Schuermans V
    Rev Infect Dis; 1987; 9 Suppl 1():S146-52. PubMed ID: 3027842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with itraconazole in systemic mycoses.
    Viviani MA; Tortorano AM; Pagano A; Vigevani GM; Gubertini G; Cristina S; Assaisso ML; Suter F; Farina C; Minetti B
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):587-93. PubMed ID: 2170478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of the systemic mycoses.
    Newberry WM
    Semin Drug Treat; 1972; 2(3):313-29. PubMed ID: 4617926
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
    Burke WA
    J Am Acad Dermatol; 1989 Dec; 21(6):1309-10. PubMed ID: 2555403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.